Heredodegenerative Disorders, Nervous System: Clinical Trials

9 trials for Heredodegenerative Disorders, Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Unknown 9

Follow Heredodegenerative Disorders, Nervous System: new trials by email Literature Review of Heredodegenerative Disorders, Nervous System trials Research Report on Heredodegenerative Disorders, Nervous System

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gandouling in the Treatment of Wilson's Disease
Gandouling - Wilson's Disease
Phase 4UnknownJun Li2402023-01-012024-02-09
The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke
Nerver growth factor (NGF) injection, Placebo injection, EA intervention - Ischemic Stroke
Phase 4UnknownThe Third Affiliated hospital of Zhejiang Chinese Medical University2882022-04-012022-07-28
Paracetamol Study in Patients With Low Muscle Mass
Paracetamol 120Mg/5mL Oral Suspension - SMA II, Cerebral Palsy
Phase 4UnknownMette Cathrine Oerngreen482019-02-182024-02-22
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
Rapamycin - Peutz-Jeghers Syndrome
Phase 4UnknownPeking Union Medical College Hospital102018-09-162019-01-23
A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
Tetrabenazine - Huntington's Disease
Phase 4UnknownWilliam Ondo, MD202018-08-012022-09-02
Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation
Rapamycin - Blue Rubber Bleb Nevus Syndrome, Venous Malformation
Phase 4UnknownPeking Union Medical College Hospital202018-07-312018-12-19
Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
trientine dihydrochloride - Wilson Disease
Phase 4UnknownUnivar BV902016-01-012017-08-23
Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
Solifenacin for 12 weeks, Solifenacin for 24 weeks - Overactive Bladder Syndrome
Phase 4UnknownNational Taiwan University Hospital2002013-05-012015-07-07
Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD
APO-clonidine - Tourette's Syndrome, Attention Deficit Hyperactivity Disorder
Phase 4UnknownUniversity Health Network, Toronto322006-09-012007-02-28

Narrower conditions

Hereditary Sensory and Autonomic Neuropathies (4)  ·  Hepatolenticular Degeneration (2)  ·  Aggression (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Blue rubber bleb nevus syndrome (1)  ·  Cerebral Palsy (1)  ·  Convalescence (1)  ·  Huntington Disease (1)  ·  Ischemic Stroke (1)  ·  Peutz-Jeghers Syndrome (1)  ·  Sleep Wake Disorders (1)  ·  Spinal Muscular Atrophies of Childhood (1)  ·  Tourette Syndrome (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Genetic Diseases, Inborn (9)  ·  Nervous System Diseases (9)  ·  Neurodegenerative Diseases (9)  ·  Brain Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Neuromuscular Diseases (5)  ·  Basal Ganglia Diseases (4)  ·  Congenital Abnormalities (4)  ·  Movement Disorders (4)  ·  Nervous System Malformations (4)  ·  Peripheral Nervous System Diseases (4)  ·  Polyneuropathies (4)  ·  Digestive System Diseases (3)

Interventions

Sirolimus (2)  ·  Acetaminophen (1)  ·  Injections (1)  ·  Nerve Growth Factor (1)  ·  Solifenacin Succinate (1)  ·  Suspensions (1)  ·  Tetrabenazine (1)  ·  Trientine (1)  ·  gluconic acid (1)

Sponsors

Peking Union Medical College Hospital (2)  ·  Jun Li (1)  ·  Mette Cathrine Oerngreen (1)  ·  National Taiwan University Hospital (1)  ·  The Third Affiliated hospital of Zhejiang Chinese Medical University (1)  ·  Univar BV (1)  ·  University Health Network, Toronto (1)  ·  William Ondo, MD (1)

Countries

China (4)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Ho-Hsiung Lin, MD, PhD (1)  ·  Jiaolin Zhou, MD (1)  ·  Karl-Heinz Weiss, MD (1)  ·  Robyn J Stephens, PhD.C.Psych. (1)  ·  William G Ondo, MD (1)

Results publications

PMID 1135616, PMID 23152677, PMID 24799137, PMID 25770310, PMID 25870613, PMID 26077459, PMID 2855531, PMID 28626052, PMID 29487073, PMID 29729645, PMID 29984566, PMID 30762779, PMID 33262243, PMID 33488759, PMID 34770113, PMID 35482910, PMID 39033586, PMID 40104015, PMID 40538652, PMID 42477731, PMID 8054244

NIH funding

2018 (1)